30+ years of experience in the nutraceutical and pharmaceutical industry. Areas of expertise include formulation development, analytical development, as well as a track record of managing people, processes and projects for the pharmaceutical and nutraceutical industries by creating, maintaining and developing products such as specialty excipients, herbal extracts, finished dosage forms and services.
Knowledgeable [Desired Position] with proven history of leading high-performing teams and executing strategic initiatives that drive organizational growth. Successfully directed cross-functional projects that resulted in significant process improvements and operational efficiencies. Demonstrated leadership and communication skills in fostering collaborative environments and delivering impactful results
Work History
Director R&D
4 Months
Sun Nutra | 06.2025 - 10.2025
Developed 4 gummy formulations using innovative base system to enhance product offerings
Facilitated production support of gummies by scaling up operations with new equipment.
Led strategic initiatives to enhance product development processes and improve time-to-market efficiency.
Directed cross-functional teams to implement best practices in operational workflows and quality assurance standards.
Oversaw budget management, ensuring alignment with organizational goals and resource allocation efficiency.
VP Operations
Nuovo Biologics LLC | undefinedundefined
Developed CMC section for new peptide API while collaborating with FDA.
Directed operational strategies to enhance efficiency across production processes.
Implemented quality control measures, ensuring compliance with industry standards and regulations.
Led cross-functional teams in process improvement initiatives, driving operational excellence.
Director of Research & Development
Avema Pharma Solutions | undefinedundefined
Head of all formulations and research. Provided marketing support to enhance product visibility and sales. Developed over 50 formulations per week for contracting company. Led all new technology developments.
Applied for five patents and developed over 9 million formulations in 7 years; formulated and developed 22 OTC products in 2009, transferring 9 to production through validation while presenting to key retail clients.
Established cGMP systems for part 211 and 111 coexisting in the same plant, including cleaning validation, process validation, and stability programs.
Developed two new technologies for key disease states, targeting potential sales of $250 million and set up phase one and two clinical trials.
Director of Business Development
LONZA BIOLOGICALS | undefinedundefined
Developed and serviced biotechnology accounts in Northeast US, delivering API production services via bacterial fermentation processes for anticancer, antibiotic, and natural product applications, including support for clinical trials.
Developed and implemented strategic partnerships to drive business growth.
Identified emerging market trends to inform product development and positioning strategies.
Led cross-functional teams to enhance customer engagement and satisfaction initiatives.
Vice President International and Marketing
PARTICLE DYNAMICS, INC. | undefinedundefined
Found, trained, and supported a global distributor and agent network for PDI with supportable contracts. This includes the development of a support group for the region via technical support, product development and new product introductions. Set up 36 distributors covering 56 key target countries under contracts. Trained all distributors and agents in two years. Doubled sales in first year in region then again year three to four, and year five. Introduced and developed 10 new products via various technologies. Supported two clinical trials external.
Led marketing strategies and initiatives for product line.
Managed a $9 million product line and handled all aspects of marketing, including new product development, market development, advertising, new product launches, pricing, and sales coordination. International duties include support of distributor network, sales development and regional expansion.
Developed 12 new products and diversified the product line from one material to 10 reducing competition and creating specialty products for the market(effervescent, Chewable tablets, etc)
Created global sales support strategy for expanded distribution network, achieving 200% growth to $1.6 million in one year.
Positioned PDI as a technology leader in pharmaceutical industry through development of technical literature, industry support initiatives, and targeted advertising.
A $25million value-added product supplier wholly owned by K-V Pharmaceuticals, a $200 million U.S. pharmaceutical company.
Global Market Manager (Pharmaceuticals)
GAF(ISP) CORPORATION | undefinedundefined
Reviewed and developed new global markets; implemented global market plans; targeted and launched new products; created P&L statements for market groups of a $110 million product line.
Increased sales from $75 million to $110 million via a strategic global advertising and account campaign.
Defined and targeted two new global market niches($5 million veterinary and $8 million dental segments).
Identified and focused on two new global market niches, including a $5 million veterinary segment and an $8 million dental segment.
Developed 6 new materials for nutraceutical applications, enhancing product offerings.
An $800 million specialty company with $120 million annual revenues from pharmaceutical chemicals.
Market Specialist (Pharmaceuticals)
GAF(ISP) CORPORATION | undefinedundefined
Researched market segments for high value products; coordinated R&D and Tech Service; developed new products, literature, and sales leads to enhance market outreach.
Developed 10 new products yielding $38 million in annual sales with 80% gross profit margins.
Researched market segments for high value products; coordinated R&D and Tech Service; developed new products, literature and sales leads; targeted markets for existing products.
Established first Tech Service systems and organized initial sales training function to improve team readiness and support product launches.
Senior Product Manager (Acetylenes)
GAF(ISP) CORPORATION | undefinedundefined
Managed product management functions for a $10 million line of 15 products.
Established GAF as preferred supplier for pharmaceutical industry through targeted promotions, technical services, and first advertising campaign.
Created mailing lists for pharmaceutical industry sales follow-up, contributing to business growth from $10 million to $35 million in two years.
Production Supervisor (Liquids and Ointments)
LEDERLE LABS | undefinedundefined
Oversaw production of $1.5 million in pharmaceutical products monthly, coordinating 5 departments and supervising 10 hourly union personnel.
Improved department performance from a $90,000 deficit to a $395,000, profit in one year.
Streamlined operations to reduce manpower by 35% while increasing output by 200% through technology and resource allocation.
Led a $1 billion pharmaceutical division of American Cyanamid, a $2.5 billion multinational corporation.
Senior Research Scientist (Process Improvement)
LEDERLE LABS | undefinedundefined
Transferred formulations from R&D and current line products, including original Centrum, Caltrate, Stresstab, and Geverbon vitamins and minerals using D/C technology instead of granulation.
Set up system for new vendor qualification
Established system for new vendor qualification to enhance supplier reliability and compliance.
Earned numerous commendations and service awards.
Retail Pharmacist
undefinedundefined
Consultant
16 Years 7 Months
N2Pharma LLC | 01.2010 - Current
Industry consultant working on key formulation and material for pharmaceutical industry customers. Managed multiple projects in pharmaceutical formulation
Developed new lubricant for industry leader in excipients, reporting to global market director.
E. Formulated over 600 Nutraceuticals products for various markets and supported launch
C. Setting up three new Nutraceutical production facilities, SOP development, formulations, ISO, etc.
Formulated and launched over 600 nutraceutical products across various markets.
G. Set up quality SOPs and forms for THREE companies, all passed FDA audit NO observations
K. Helped audit and set up three Nutraceutical plants, two older, one new, to CFR 21 Part 111
Developed new lubricant for industry leader in excipients.
D. Coordinated deal with 6 major generic companies to SouthEast Asian company for exclusive distribution
Audited and established compliance for three nutraceutical plants, ensuring adherence to CFR 21 Part 111.
L. Developed two patents for clients on technologies in medical devices.
M. Created submission for 510K on oral dental device and reviewed science, all FDA forms
N. Created submission for 510K on new medicated dental floss system and reviewed science all FDA forms
O. Helped create transNasal device to deliver drugs nasally, created 510K file.
Education
B.S - Pharmacy
University of Missouri | Kansas City
B.A. - Biological Sciences, Chemistry
University of Missouri | Columbia
Skills
• CGMP audit development
CGMP documentation
• Technical review
• Process optimization
• Manufacturing operations oversight
• Process improvement
• Training documentation
• Continuous training documentation
Advanced Formulation Research
Decision-making
Verbal and written communication
Relationship building
Affiliations
AAPS Founding member, National Vendor Rep., PT section
NJPDG Program and Arrangements committee, Membership Chair
PDG Member
DCAT Member
CRN Calcium Technical Representative
PRESENTATIONS
Pharm Tech Meeting (Tablet Disintegrants)
AAPS Annual Meeting (Excipient Global Registration)
Pharm Tech Meeting Mexico City, Mexico (Novel tablet Technologies)
CPhI China, Beijing China (New Effervescent Technologies)
Pharm Tech Conference, Jakarta, Indonesia (Formulation Technologies 2000)
Neil Ross, A Firsthand account of Hiring a CMO, Life Science Leader, special issue, 8/2011, page 38
PATENTS
Stability additives for dry DHA formulations United States US 2011/0165233 A1 date Issued July 7, 2011 Way to stabilize DHA in a tablet or capsule formulation at high dose in dry stable powder form
Chewable electrolyte tablet United States US 2006/0068005 A1 date Issued March 30, 2006 A way to deliver CORRECT electrolytes and CORRECT water volumes and doses to athletes without having to carry a bottle
TASTE MASKING OF ANESTHETICS AND ANALGESICS United States PCT/US14/27370 date Issued March 14, 2014 Way to remove taste issues from anesthetics for dental work via injection, not an oral cream which does not work.
MULTISTRAIN PROBIOTIC BLENDS FOR TREATMENT OF GASTROINTESTINAL CONDITIONS AND IMPROVING OR MAINTAINING GASTROINTESTINAL HEALTH United States 67/175,898 date Issued June 16, 2015 Click to edit patent descriptionA way to blend certain probiotics at specific levels with a prebiotic to provide a specific response